Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

AI Clinical Trial Protocol Feasibility Tools Is Projected to Grow

3 November 2026 · By · Wire by Fusion42

Published

3 November 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United Kingdom

◆ Source

Read at natlawreview.com →

◆ Verified

Fusion42 · 3 November 2026 · Fusion42 review

The AI clinical trial protocol feasibility tool market is projected to grow from $0.83 billion in 2025 to $2.76 billion by 2030, with a CAGR of approximately 27%, driven by demand for faster trial approvals, decentralized trial models, and precision medicine integration.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ ◆ The Wire takeaway

You can exploit AI's rise in clinical trial planning to cut delays and boost trial success. Tools that tailor trials to patient genetics and optimise recruitment open faster paths to approval and lower costs.

◆ Coverage

1 source · 3 Nov 2026

◆ Related on Wire

◆ Topics

Digital Healthclinical-trialsAI-toolsprecision-medicinedigital-healthtrial-optimization